Indeed, many comorbidities associated with increased risk of mortality in COVID-19, such as obesity, diabetes, and heart failure, are associated with increased levels of ACE2 [39,40]. This evidence concerns the gene ACE2 and obesity due to melanocortin 4 receptor deficiency.